Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcipotriene + dimethicone is a **topical combination product** containing calcipotriene, a synthetic vitamin D3 analogue, and dimethicone, an emollient. **Calcipotriene** acts on the vitamin D receptor to reduce keratinocyte proliferation and modulate immune responses in the skin, leading to improvement in conditions like plaque psoriasis. **Dimethicone** is an inert silicone-based oil used to moisturize and protect the skin, enhancing the barrier function and reducing irritation. This combination is formulated as a topical cream, primarily indicated for the treatment of plaque psoriasis, with calcipotriene responsible for the primary pharmacological action and dimethicone serving to improve tolerability and skin hydration[7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcipotriene + dimethicone.